A new study published in The Journal of Neuroscience suggests that a specific genetic variant alters how organisms respond to alcohol. The research identifies the chrna3 gene as a primary regulator of alcohol sensitivity and indicates that defects in this gene can lead to increased tolerance.
Alcohol use disorders represent a significant global health burden, yet understanding the biological mechanisms behind them remains a challenge. Genetic studies in humans have frequently associated a cluster of genes known as CHRNA5-A3-B4 with nicotine and alcohol dependence. This cluster encodes subunits for nicotinic acetylcholine receptors, which are proteins involved in signaling within the nervous system.
While statistical associations exist, pinning down the specific contribution of the CHRNA3 gene has been difficult. Mammalian models lacking this gene typically do not survive past the neonatal stage, which prevents scientists from observing adult behaviors related to substance use.
The research team aimed to bypass this obstacle by using zebrafish, a model organism that shares substantial genetic similarity with humans and can survive with the mutation. They sought to determine if disabling the chrna3 gene would directly change voluntary alcohol consumption and physiological reactions to the substance.
To investigate this, the researchers employed CRISPR-Cas9 gene-editing technology to create a line of zebrafish with a mutation in the chrna3 gene. This mutation introduced a premature stop signal in the genetic code, resulting in a truncated and non-functional protein.
The team then compared the behavior of these mutant fish against wild-type fish with fully functional genes. They utilized approximately five-week-old juvenile zebrafish for the behavioral experiments. At this stage of development, the fish exhibit complex locomotor behaviors comparable to adults but allow for higher throughput testing.
The primary method for assessing behavior was a refined setup called the Self-Administration Zebrafish Assay. This apparatus featured a tank divided into distinct zones. A closed-loop tracking system monitored the movement of the fish.
When a fish entered a designated stimulus zone, the system automatically dispensed a solution containing alcohol. If the fish entered a control zone, the system dispensed water. This design allowed the animals to make active choices about their alcohol intake and regulate their exposure levels dynamically.
The study first established a baseline for normal behavior using wild-type fish. These animals exhibited a biphasic response to alcohol. At lower concentrations, roughly equivalent to 0.5 percent, the fish showed an initial attraction and spent more time in the alcohol-dispensing zone.
However, as the concentration increased or exposure time lengthened, their behavior shifted. When the effective concentration reached approximately 0.7 percent, the wild-type fish began to avoid the stimulus zone. This suggests that for typical organisms, alcohol acts as a reward at low doses but becomes aversive at higher doses.
The behavior of the chrna3 mutant fish presented a distinct contrast. Like the wild-type group, the mutants showed an initial attraction to the lower concentrations of alcohol. However, they did not exhibit the subsequent switch to avoidance.
Even as the concentration increased to levels that repelled the wild-type fish, the mutants continued to self-administer the substance. The typical aversion mechanism appeared to be blunted or absent. This resulted in the mutant fish exposing themselves to significantly higher volumes of alcohol over the course of the experiment.
To understand the physiological reasons for this difference, the researchers conducted a separate shoaling cohesion assay. This test measures anxiety and sedation by observing how groups of fish swim together.
Under normal conditions, zebrafish swim in tight groups or shoals when they feel anxious. Alcohol typically acts as an anxiolytic, which reduces anxiety and causes the shoal to loosen. At higher doses, alcohol acts as a sedative, causing the fish to swim more slowly.
In the wild-type groups, exposure to 0.5 percent alcohol caused the shoals to spread out, indicating reduced anxiety. Exposure to 1 percent alcohol resulted in reduced swimming speed, indicating sedation.
The chrna3 mutants reacted differently. They maintained tighter shoaling formations even when exposed to alcohol, suggesting they did not experience the same level of anxiety reduction. Additionally, they resisted the sedative effects of the higher dose. The mutants continued to swim actively at concentrations that significantly slowed down the wild-type fish.
These behavioral findings suggest that the functional chrna3 gene acts as a regulatory brake. It appears to mediate the aversive and sedative effects of alcohol that typically limit consumption. Without this genetic brake, the negative feedback loops that discourage high alcohol intake are weakened. The mutants effectively displayed a higher tolerance for the substance, requiring larger doses to elicit behavioral changes that appeared rapidly in normal fish.
The researchers also analyzed the gene expression profiles of adult brains to identify molecular changes. They sequenced the RNA from whole brains of both wild-type and mutant fish. The analysis revealed that the loss of chrna3 function triggered widespread compensatory changes. Approximately 1,600 genes showed significant alterations in their expression levels.
Among the most notable changes were alterations in genes responsible for other neurotransmitter systems. The expression of receptors for glutamate, the main excitatory neurotransmitter, and GABA, the main inhibitory neurotransmitter, was modified.
This indicates that the brain attempted to rebalance its signaling networks in the absence of normal cholinergic activity. Additionally, the study found downregulation of other genes in the same cluster, specifically chrna5 and chrnb4. This suggests that the function of these receptor subunits is tightly coordinated and that a defect in one can disrupt the entire system.
The study has certain limitations that frame the interpretation of the results. The mutation was present in all cells of the zebrafish, which prevents the researchers from pinpointing the exact brain region responsible for the behavior.
While the study implicates the whole brain, specific circuits likely drive the attraction and aversion responses. The researchers utilized juvenile and adult fish for different parts of the study, and while their brains are similar, developmental differences could play a role.
Future research aims to address these specific neural mechanisms. The team plans to investigate whether similar variants in the human CHRNA3 gene correlate with altered alcohol sensitivity in people.
They also intend to study the interactions between the different genes in the cluster to understand how they collectively influence addiction risk. Developing models with mutations in multiple genes will help disentangle the complex genetic architecture of substance use disorders.
The study, “chrna3 modulates alcohol response,” was authored by Joshua Raine, Caroline Kibat, Tirtha Das Banerjee, Antónia Monteiro, and Ajay S. Mathuru.